<DOC>
	<DOCNO>NCT00510159</DOCNO>
	<brief_summary>The purpose study evaluate efficacy praziquantel versus As+SMP ( Co-Arinate FDC Â® ) treatment Schistosoma haematobium 6-15 year old Malian child . The nul-hypothesis study combination As+SMP effective praziquantel treatment S. haematobium infect child .</brief_summary>
	<brief_title>Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine Treating Schistosomiasis</brief_title>
	<detailed_description />
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Sulfalene</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Aged 615 year In good health , accord study doctor Suffering urinary schistosomiasis , diagnose presence S. haematobium egg urine . Residents Djalakorodji Capable take oral medication Written inform consent participate study , obtain parent legal guardian . Weighing 50 kg Being pregnant lactating time study Patient severe concomitant disease , determine clinical examination , cerebral cysticercosis , HIV , ... Signs severe malnutrition ( child weighing/measuring 3 standard deviation less 70 % median standard reference value determine WHO , systemic oedema affect foot ) . Hypersensitivity As , SMP PZQ Having take antimalarial antischistosomal medication study . Having participate previous similar study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Schistosoma haematobium</keyword>
	<keyword>Praziquantel</keyword>
	<keyword>Artesunate + Sulfamethoxypyrazine/pyrimethamine</keyword>
	<keyword>Randomized double blind placebo control clinical trial</keyword>
</DOC>